Interaction of V^VO₂-hydrazonates with lysozyme.

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Structural Biology

Background:

• Vanadium compounds (VCs) possess significant pharmacological properties, particularly for cancer and diabetes treatment.
• Understanding vanadium compound-protein interactions is crucial for elucidating their therapeutic effects and mechanisms of action.
• VC1 and VC2 are promising vanadium(V) complexes with potential anticancer activity.

Purpose of the Study:

• To investigate the interaction between two vanadium complexes, VC1 and VC2, and hen egg white lysozyme (HEWL).
• To elucidate the binding mode and structural consequences of VC1 and VC2 interaction with HEWL.
• To explore the potential for supramolecular association upon complex binding to the protein.

Main Methods:

• UV-vis spectroscopy
• Fluorescence spectroscopy
• Circular dichroism
• X-ray crystallography

Main Results:

• VC1 and VC2 interact with HEWL without altering the protein's secondary or tertiary structure.
• Crystallographic studies reveal non-covalent binding of the vanadium complexes or their fragments to HEWL.
• Bound VC1 and VC2 molecules form supramolecular associations stabilized by stacking interactions.

Conclusions:

• VC1 and VC2 bind to HEWL through non-covalent interactions, preserving protein structure.
• The formation of supramolecular assemblies upon binding may influence the biological activity of vanadium compounds.
• This study provides insights into vanadium compound-protein interactions relevant to drug design.